BRITTANY GARDNER: Open Payments
NPI 1720552268 · QUITMAN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,452 in 101 payments from 19 companies in 2025. Trend: 2023 $1,328 · 2024 $1,782 · 2025 $1,452
Food & beverage: $1,357Education: $95
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $208 |
| ABBVIE INC. | 22 | $202 |
| UCB, Inc. | 11 | $170 |
| Janssen Biotech, Inc. | 7 | $152 |
| Galderma Laboratories, L.P. | 12 | $136 |
| Lilly USA, LLC | 4 | $103 |
| Incyte Corporation | 5 | $96 |
| Organon LLC | 5 | $70 |
| Amgen Inc. | 3 | $58 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $51 |
Products named: COSENTYX, Bimzelx, TREMFYA, NEMLUVIO, RINVOQ, EBGLYSS, OPZELURA, SKYRIZI.
Industry payments across MS — which companies pay providers there.
